The global Blockchain In Pharmaceutical market size is predicted to grow from US$ 6825 million in 2025 to US$ 102430 million in 2031; it is expected to grow at a CAGR of 57.1% from 2025 to 2031.
Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.
Market Drivers
1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.
2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.
3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.
4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.
5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.
LPI (LP Information)' newest research report, the “Blockchain In Pharmaceutical Industry Forecast” looks at past sales and reviews total world Blockchain In Pharmaceutical sales in 2024, providing a comprehensive analysis by region and market sector of projected Blockchain In Pharmaceutical sales for 2025 through 2031. With Blockchain In Pharmaceutical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blockchain In Pharmaceutical industry.
This Insight Report provides a comprehensive analysis of the global Blockchain In Pharmaceutical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blockchain In Pharmaceutical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blockchain In Pharmaceutical market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blockchain In Pharmaceutical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blockchain In Pharmaceutical.
This report presents a comprehensive overview, market shares, and growth opportunities of Blockchain In Pharmaceutical market by product type, application, key players and key regions and countries.
Segmentation by Type:
Private Blockchain
Hybrid Blockchain
Segmentation by Application:
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook